MedPath

Idiopathic Pulmonary Fibrosis (IPF) and the 3 Minutes Sit-to-stand Test

Not Applicable
Completed
Conditions
Idiopathic Pulmonary Fibrosis
Registration Number
NCT03268915
Lead Sponsor
University Hospital, Grenoble
Brief Summary

This study is designed to evaluate the reproductibility and the performance of the 3 minutes sit-to-stand test in patients with idiopathic pulmonary fibrosis.

To do this, the investigators are recruiting 40 patients with idiopathic pulmonary fibrosis in 2 centers (Grenoble university hospital and Lyon university hospital).

Patients had to achieve an effort test on a cycle ergometer. 2 visits are planned in the hospital. During each visit, patients will perform a 3 minutes sit-to-stand test, a 1 minute sit-to-stand test and a 6 minutes walk test. During the second visit, patients will also perform a 3 minutes sit-to-stand test with measurement of oxygen uptake.

The investigators will then analyse the results by comparing numbers of cycle, functional response and symptoms during the 3 minutes sit-to-stand test of the 2 visits. The investigators will also compare the functional response obtained during the 3 minutes sit-to-stand test, the 1 minute sit-to-stand test and the 6 minutes walk test.

Finally, the investigators will compare the maximal values of oxygen uptake, respiration rate and expired volume obtained during the 3 minutes sit-to-stand test to the effort test on cycle ergometer.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
35
Inclusion Criteria
  • man or woman aged less than 85 years
  • patients with Idiopathic Pulmonary Fibrosis without any acute exacerbation during 4 months before the inclusion
  • Non-opposition to participation in research
  • Patient with 6 minutes walk test > 200 meters (with or without oxygen therapy)
Exclusion Criteria
  • Patient with reduced locomotor activity, or joint pain that compromises the performance of the tests
  • Patient with 6 minutes walk test < 200 meters
  • Patient with an other etiology of pulmonary fibrosis
  • Other significant pulmonary diseases
  • Patient with unstable cardiac disease
  • Patient who may be, according to the investigator's assessment, not cooperating or respecting the obligations inherent in participating to the study.
  • Opposition to participation in research

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Reproductibility of the 3 minutes sit-to-stand test in patient with idiopathic pulmonary fibrosis2 days

Evaluate the reproductibility for the number of rise and down during the 3 minutes sit-to-stand test of the 2 visits (the investigators will compare the number of rise and sit during the 3 minutes sit-to-stand test of the 2 visits to see if they are similar)

Secondary Outcome Measures
NameTimeMethod
1 minute sit-to-stand test compared to 3 minutes sit-to-stand: oxygen saturation2 days

Compared oxygen saturation during the 3 minutes sit-to-stand test with 1 minute sit-to-stand test

Functional response during the 3 minutes sit-to-stand test: Heart rate2 days

Evaluate the reproductibility of functional response (heart rate) during the 3 minutes sit-to-stand test

Functional response during the 3 minutes sit-to-stand test: symptoms2 days

Evaluate the reproductibility of functional response (symptoms) during the 3 minutes sit-to-stand test

3 minutes sit-to-stand test compared to the 6 minutes walk test: symptoms2 days

Compared symptoms during the 3 minutes sit-to-stand test to the 6 minutes walk test

Functional response during the 3 minutes sit-to-stand test: Oxygen saturation2 days

Evaluate the reproductibility of functional response (oxygen saturation) during the 3 minutes sit-to-stand test

3 minutes sit-to-stand test compared to the 6 minutes walk test: oxygen saturation2 days

compared oxygen saturation during the 3 minutes sit-to-stand test to the 6 minutes walk test

3 minutes sit-to-stand test compared to the 6 minutes walk test: heart rate2 days

Compared heart rate during the 3 minutes sit-to-stand test to the 6 minutes walk test

1 minute sit-to-stand test compared to 3 minutes sit-to-stand: heart rate2 days

Compared heart rate during the 3 minutes sit-to-stand test with 1 minute sit-to-stand test

1 minute sit-to-stand test compared to 3 minutes sit-to-stand: symptoms2 days

Compared symptoms during the 3 minutes sit-to-stand test with 1 minute sit-to-stand test

Trial Locations

Locations (2)

CHU Grenoble Alpes

🇫🇷

La Tronche, France

Groupement Hospitalier Est

🇫🇷

Lyon, France

CHU Grenoble Alpes
🇫🇷La Tronche, France
© Copyright 2025. All Rights Reserved by MedPath